cardiomyopathy

- The primary endpoint was met (Win Ratio of 1.8) with a highly statistically significant p-value (p<0.0001); this primary endpoint result consistently favored acoramidis treatment…

Combining two types of heart scan techniques could help doctors to detect the deadly heart condition hypertrophic cardiomyopathy (HCM) before symptoms and signs on conventional tests appear,…

PALO ALTO, Calif., July 14, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases and…

Newark, New Castle, USA, June 22, 2023 (GLOBE NEWSWIRE) -- Growth Plus Reports estimated the size of the global market for hypertrophic cardiomyopathy in 2022 to be worth US$ 1.12…

NEW ORLEANS -- The concept of using myocardial viability to guide revascularization in severe ischemic cardiomyopathy was laid…

Researchers from the group of Eva van Rooij in collaboration with the UMC Utrecht identified a new mutation that leads to the cardiac disease arrhythmogenic cardiomyopathy (ACM). They…

<!-- Name:DistributionId Value:8754801 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

While management of dilated cardiomyopathy (DCM) patients whose ejection fraction recovers…

TN-401 is being developed for the treatment of genetic arrhythmogenic right ventricular cardiomyopathy (ARVC) caused by mutations in the PKP2 gene Orphan Drug Designation for TN-401 is the…

Children with cardiomyopathy are one of the highest-risk pediatric groups for developing thrombosis, along with kids with Fontan…